Clinical Trial Update: Glycyphagus Domesticus Allergen Extract. Determination of the in Vivo Biological Activity in Histamine Equivalent Units (HEP). [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the in vivo biological activity of Glycyphagus domesticus allergen extract using histamine equivalent units (HEP) as the measure. The s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Conjunctivitis
• Allergic Rhinitis

Drugs mentioned

• Glycyphagus Domesticus Allergen Extract (Glycyphagus domesticus allergen extract)

Snippet

Sponsor: Laboratorios Leti, S.L. | Conditions: Rhinitis, Allergic, Seasonal, Conjunctivitis, Allergic | Phase 2 | Status: COMPLETED